Presentation is loading. Please wait.

Presentation is loading. Please wait.

Evaluation of Abnormal Liver Tests

Similar presentations


Presentation on theme: "Evaluation of Abnormal Liver Tests"— Presentation transcript:

1 Evaluation of Abnormal Liver Tests
Timothy R. Morgan

2 Outline What are Liver Tests?
Where in the liver do the “Liver Tests” come from? Normal values Tests of “liver function” vs. “liver injury” Three questions! Hepatocellular vs. Obstructive Common causes of hepatocellular and obstructive Work-up algorithm Evaluation of severity of liver disease

3 Liver Tests Bilirubin, total, direct <1.2 / <0.3 mg/dL
Albumin – 4.8 g/dL Aspartate aminotransferase (AST) 10 – 32 IU/mL Alanine aminotransferase (ALT) 3 – 30 IU/mL Alkaline phosphatase 30 – 115 IU/mL Gamma glutamyltransferase 2 – 65 U/mL

4 Normal Liver: H&E Stain
Hepatocyte AST ALT Albumin INR Bilirubin Cerulo α-1 AT THV Bile Ducts Alk Phos GGT Bilirubin Portal Vein Bile Duct Portal Portal

5 Marker of injury, not function !
Liver Blood Tests Markers of Cell Injury AST ASpartate aminoTransferase Also known as Serum Glutamic-Oxaloacetic Transaminase (SGOT) AST found in heart, skeletal muscle, brain, gastric mucosa, kidney, pancreas, spleen, lung, and red blood cells 90% of AST in blood is released from liver. ALT ALanine aminoTransferase Also known as Serum Glutamic-Pyruvic Transaminase (SGPT) ALT found predominantly in liver, very small amounts in kidney and muscle Almost all ALT in blood is released from the liver Both are key enzymes in converting amino acids into high energy molecules for gluconeogenesis Both are intra-cellular enzymes – when their levels increase in the blood, it means that cells are dying Marker of injury, not function !

6 Markers of Cholestasis
Liver Blood Tests Markers of Cholestasis Alkaline Phosphatase Found in liver, bone, gut, and placenta Source of alk phos confirmed by elevations in Gamma Glutamyl Transferase (GGT) Predominantly on the canalicular membrane of the hepatocyte Alk phos enzyme is induced by elevated levels of bile acids, which can occur either from bile duct obstruction or hepatocyte injury/dysfunction Total Bilirubin Comprised of both Conjugated (direct) and Unconjugated (indirect) bilirubin Bilirubin is produced during the breakdown of hemoglobin Conjugation occurs in the hepatocyte Bilirubin rises due to over production (i.e.. hemolysis), under secretion (i.e.. biliary obstruction, liver injury, shunt), or impaired metabolism (i.e.. Gilbert’s syndrome) Often referred to as “cholestatic enzymes” Reflect issues surrounding hepatic secretory function

7 Markers of Impaired Synthetic Function
Liver Blood Tests Markers of Impaired Synthetic Function Albumin Blood protein that is made in the liver Half life of endogenous albumin is days (compared to T½ of infused albumin, which is ~8 hours) Production is inhibited by physiologic stress (surgery, infection, acute disease) Production is inhibited in advanced stages of chronic liver disease INR Reflects clotting cascade function of the extrinsic clotting pathway (factors II, V, VII, X) All extrinsic factors made by the liver Factors II, V, VII are also Vitamin K dependent Rise in INR reflects deficient production of at least one of the cofactors (in absence of vitamin K deficiency) Factor VII has the shortest half life of all the cofactors (3 hrs), and is a reasonable measure of immediate liver function These are true “liver function” tests

8 Liver Function vs. Liver Injury
Bilirubin, total, direct Albumin INR Liver Injury AST ALT (GGT) (alk phos)

9 Three Questions!! What is the cause of the liver test abnormalities?
How “bad” is the liver injury? What are we going to do about it?

10 What is the cause of liver injury?
History Alcohol use, medications, IVDU, past abnormal liver tests, past jaundice, family history, PE Itching, jaundice, liver size/firmness, spleen Spider angioma, ascites, encephalopathy Lab Tests Liver panel, comprehensive metabolic panel CBC with diff INR

11 Hepatocellular vs. Obstructive
AST and ALT alkaline phosphatase and bilirubin “Obstructive” alkaline phosphatase, bilirubin and GGT AST and ALT

12 Common Causes of Hepatocellular Injury (AST and ALT)
Viral hepatitis (A, B, C) HBsAg, anti-HCV, PCR Alcohol History, blood alcohol Drugs/medications history, stopping drug Fatty Liver BMI, FBS, TG, DM Autoimmune ANA, SMA Hemochromatosis Iron/TIBC/Ferritin, HFE Wilson disease Ceruloplasmin Alpha-1 antitrypsin deficiency level, phenotype CHF, ischemic history, time

13 Hepatocellular Injury Raised ALT and AST
History Physical Examination Age, gender chronic liver disease Travel, (firm liver, spleen palp) Medications weight Alcohol, IVD Transfusions HCV Ab ANA Iron/TIBC Ceruloplasmin Alpha-1 AT HBsAg SMA Ferritin level HCV-PCR HFE gene phenotype Liver Biopsy

14 “Obstructive” Bilirubin and Alkaline Phosphatase
Choledocholethiasis (Common bile duct stones) Cancer with obstruction of CBD (pancreatic, cholangiocarcinoma, gallbladder) Cancer metastatic to liver (e.g., colon, pancreas) Mass in liver (granulomas, abscess) Drug injury (cholestasis) Primary biliary cirrhosis Sclerosing cholangitis Third trimester of pregnancy

15 Diagnostic Tests for Obstructive
Ultrasound of liver, gallbladder pancreas, bile ducts CT, MRI Endoscopic retrograde cholangiopancreatography, Endoscopic ultrasound Antimitochondrial antibody (AMA) Liver biopsy

16 Alkaline Phosphatase, Bilirubin, GGT
“Obstruction” Alkaline Phosphatase, Bilirubin, GGT History Physical Examination Age, gender chronic liver disease Jaundice (firm liver, spleen palp) Medications weight Weight loss, itching AMA US, CT, MRI AMA + Liver Biopsy Mass or Non-dilated Ducts Liver Biopsy Dilated Bile Ducts ERCP / EUS

17 How Bad is the Liver Disease?
History Ascites, variceal bleeding, encephalopathy Physical Examination Firm liver, splenomegaly Spider angiomas, palmar erythema Ascites, hepatic encephalopathy Laboratory tests Albumin, bilirubin (direct), INR Platelet, WBC Liver Biopsy

18

19 Stages of Fibrosis In Chronic Hepatitis
HCV - Natural History Stages of Fibrosis In Chronic Hepatitis Portal Periportal Septal Cirrhosis 1 2 3 4 Slide 202 Stages of Fibrosis In Chronic Hepatitis Most pathologist use a four-point system for staging fibrosis in chronic hepatitis, based on the amount of fibrosis seen in relation to the portal tract [Desmet VJ et al., Hepatology 1994;19:1513]. In stage 1, an increased amount of collagen expands the portal area. In stage 2, strands of fibrosis extend out from portal areas but do not interconnect. In stage 3, strands of fibrosis begin to connect from one portal tract to another, forming septa. In stage 4, or cirrhosis, the septa have formed a network of interconnecting bands surrounding nodules of liver cells. At this point, the original architecture of the liver has been completely transformed. (The Metavir Scoring System is described in more detail in slide 364.) Photo courtesy of Tom Smyrk, MD, Mayo Medical Center, Rochester, MN

20 What are we going to do about the liver disease?
Depends on cause of liver disease, severity of liver disease and patient’s wishes

21 Case 1 23 yo Asian male college student.
Maternal grandmother died of liver disease No alcohol use, no IVDU Not on any medicines, no prior history of liver disease PE Liver palpable, slightly firm

22 Case 1 Lab tests AST 84 IU/mL ALT 129 IU/mL
Alkaline phosphatase 114 IU/mL Total bilirubin IU/mL Direct bilirubin IU/mL Albumin g/dL Total protein g/dL

23 Case 1 HBsAg positive Hepatitis C antibody negative
Iron/TIBC/Ferritin 98/278/351 ANA negative Alpha-1 antitrypsin 159 (normal) Ceruloplasmin 33 (normal)

24 Case 3 32 yo man was at health fair and had blood tests showing elevated ALT and AST No prior liver disease, no medications, no family history of liver disease, no IVDU Drinks 2-3 beers on weekend days PE: normal

25 Case 3 Lab tests AST 61 IU/mL ALT 88 IU/mL
Alkaline phosphatase 78 IU/mL Bilirubin T/D / 0.1 mg/dL Albumin mg/dL

26 Case 3 differential Diagnosis
Viral hepatitis Drugs Alcohol Hemochromatosis Wilson disease Alpha-1 antitrypsin deficiency Autoimmune disease

27 Case 3: Test Results HBsAg negative HCV antibody negative ANA negative
Alpha-1 antitrypsin normal Ceruloplasmin normal Iron/TIBC/Ferritin 289/305/1740 HFE gene double mutation of C282Y

28 Hemochromatosis (Prussian Blue Stain

29 Case 4 23 yo female office assistant seen in ER for severe headache. Elevated ALT No personal or family history of liver disease, no IVDU, no abdominal pain 3-4 drinks/day on weekends OCP PE: ?? Palpable spleen, otherwise normal

30 Case 4 Lab results AST 91 IU/mL ALT 133 IU/mL
Alkaline phosphatase 145 IU/mL Bilirubin T/D / 0.4 IU/mL Albumin IU/mL Total protein IU/mL

31 Case 4: Differential Diagnosis
Alcohol Viral hepatitis Medications Autoimmune Hemochromatosis Wilson Alpha-1 antitrypsin deficiency

32 Case 4 Test Results HBsAg negative Hepatitis C antibody negative
Iron/TIBC/Ferritin 68/389/154 Ceruloplasmin 66 Alpha-1 antitrypsin normal ANA 1:320 Smooth muscle antibody 1:64

33 Autoimmune Hepatitis Mieli-Vergani, G. & Vergani, D. (2011) Autoimmune hepatitis Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

34 Case 5 48 yo female with mildly abnormal liver tests for past few years Medications for Maxide and simvastatin, estrogen Alcohol 1 drink/day, no IVDU, or surgery, Mother had hypertension, father had diabetes and MI PE: BMI 31

35 Case 5 Labs AST 53 IU/mL ALT 69 IU/mL Alkaline phosphatase 154 IU/mL
Bilirubin T/D / 0.2 Albumin g/dL Total protein g/dL Triglycerides Glucose mg/dL

36 Case 5 Differential Diagnosis
Viral hepatitis Alcohol Fatty liver Autoimmune Hemochromatosis Alpha-1 antitrypsin Wilson Medications

37 Case 5 Test Results HBsAg negative Hep C antibody and PCR negative
Iron/TIBC/Ferritin 126/349/233 ANA and SMA negative Ceruloplasmin normal Alpha-1 antitrypsin normal Glucose mg/dL Insulin elevated (2x)

38 Steatosis THV THV: terminal hepatic venule
The lesions of NASH in adults (without bridging or advanced fibrosis) are predominantly in zone 3 as noted by the terminal hepatic venule. The steatosis, as seen here, may be mixed macro and smalldroplet or microvesicular steatosis. THV: terminal hepatic venule

39 Case 6 45 yo asymptomatic woman. No history of alcohol use or IVDU.
No prescription meds. Occasionally takes acetaminophen, ibuprofen, and various alternative meds. Normal physical examination

40 Case 6 (lab tests) Total Bilirubin 1.2 mg/dl
Direct Bilirubin 0.3 mg/dl Alkaline phosphatase 437 IU/mL AST IU/mL ALT IU/mL Albumin g/dL Total protein g/dL

41 Case 6 Differential Diagnosis
Choledocholethiasis Drugs Primary biliary cirrhosis Metastatic disease to liver Granulomas in liver Ultrasound of liver and bile ducts Antimitochondrial antibody

42 Primary Biliary Cirrhosis
(Florid Duct Stage)

43 Case 7 66 yo man with 20 lb weight loss who says his eyes turned yellow yesterday. No prior liver disease, 1-2 drinks per day, Uncle had colon cancer, mother had breast cancer PE: jaundice, mildly tender RUQ

44 Case 7 Lab Tests AST 98 IU/mL ALT 112 IU/mL Albumin 3.5 g/dL
Bilirubin (T/D) / 5.5 mg/dL Alk phos U/mL GGT U/mL

45 Case 7 Differential Dx Biliary tract obstruction Pancreatic cancer
Cholangiocarcinoma Choledocholethiasis (CBD stone)

46 ERCP Double-Duct Sign

47 Case 8 25 yo man with depression
Uses multiple drugs: heroin, ecstasy, methamphetamine, marijuana; most recently several days prior to admission No significant alcohol use No regular medications PE: normal

48 Case 8 Lab Tests AST 2150 IU/mL ALT 2005 IU/mL Alk Phos 78 IU/mL
Bilirubin T/D 4.3/1.4 mg/dL Albumin g/dL T. Protein g/dL INR Creatinine mg/dL

49 Case 8: Differential Diagnosis
Acute viral hepatitis (A, B, C, E) Drug toxicity (Acetaminophen) Ischemic hepatitis Autoimmune hepatitis Wilson disease

50 Case 8: Lab Results HBsAg Negative HBcAb-IgM Negative
Hepatitis A-IgM Negative Hepatitis C Ab Negative Hepatitis C PRC Negative ANA Negative Ceruloplasmin 22 (normal: 20 – 60) Acetaminophen 87

51 Case 2 67 yo man No alcohol or tobacco, no IVDU
no family history of liver disease lisinopril and simvastatin PE Unremarkable

52 Case 2 Lab Tests AST 35 IU/mL ALT 78 IU/mL
Alkaline phosphatase 106 IU/mL Bilirubin T/D / 0.2 mg/dL Albumin mg/dL

53 Case 2 Differential Diagnosis
Hepatitis B, Hepatitis C Hemochromatosis Wilson, autoimmune, drugs Alpha-1 antitrypsin deficiency

54 Case 2 Test results HBsAg negative Hepatitis C antibody negative
Negative HCV-RNA Iron/TIBC/Ferritin 189/402/255 ANA negative Ceruloplasmin normal Alpha-1 antitrypsin 39 (90-199) Phenotype S/Z

55 Alpha-1 antitrypsin Liver Histology

56 Three Questions!! What is the cause of the liver test abnormalities?
How “bad” is the liver injury? What are we going to do about it?

57 Hepatocellular vs. Obstructive
AST and ALT alkaline phosphatase and bilirubin “Obstructive” alkaline phosphatase, bilirubin and GGT AST and ALT

58 Common Causes of Hepatocellular Injury (AST and ALT)
Viral hepatitis (A, B, C) HBsAg, anti-HCV, PCR Alcohol History, blood alcohol Drugs/medications history, stopping drug Fatty Liver BMI, FBS, TG, DM Autoimmune ANA, SMA Hemochromatosis Iron/TIBC/Ferritin, HFE Wilson disease Ceruloplasmin Alpha-1 antitrypsin deficiency level, phenotype CHF, ischemic history, time

59 Hepatocellular Injury Raised ALT and AST
History Physical Examination Age, gender chronic liver disease Travel, (firm liver, spleen palp) Medications weight Alcohol, IVD Transfusions Anti-HCV ANA Iron/TIBC Ceruloplasmin Alpha-1 AT HBsAg SMA Ferritin level HCV-PCR HFE gene phenotype Liver Biopsy

60 “Obstructive” Bilirubin and Alkaline Phosphatase
Drug injury (cholestasis) Choledocholethiasis (Common bile duct stones) Cancer with obstruction of CBD (pancreatic, cholangiocarcinoma, gallbladder) Cancer metastatic to liver (eg, colon, pancreas) Mass in liver (granulomas, abscess) Primary biliary cirrhosis Sclerosing cholangitis Women in third trimester

61 Alkaline Phosphatase, Bilirubin, GGT
“Obstruction” Alkaline Phosphatase, Bilirubin, GGT History Physical Examination Age, gender chronic liver disease Jaundice (firm liver, spleen palp) Medications weight Weight loss, itching AMA US, CT, MRI AMA + Liver Biopsy Mass or Non-dilated Ducts Liver Biopsy Dilated Bile Ducts ERCP

62 “Liver Function” Tests
Bilirubin, total, direct Albumin, (total protein [globulin]) Aspartate aminotransferase (AST) Alanine aminotransferase (ALT) Alkaline phosphatase Gamma glutamyltransferase INR Platelets WBC, MCV, hemoglobin

63 “Liver Injury” Tests Bilirubin, total, direct
Albumin, (total protein [globulin]) Aspartate aminotransferase (AST) Alanine aminotransferase (ALT) Alkaline phosphatase Gamma glutamyltransferase INR Platelets WBC, MCV, hemoglobin

64 Globulins (total protein – albumin)
Made by liver Decreased due to low production (cirrhosis), loss through kidney (nephrotic syndrome), catabolism (burns, malnutrition) and increased total body water (cirrhosis) Globulins (total protein – albumin) Elevated in multiple myeloma, autoimmune liver disease, cirrhosis of many causes, If elevated, order SPEP, UPEP

65 Gamma glutamyltransferase (GGTP)
Alkaline phosphatase Found on bile canniculus and in bone Increased in bile duct obstruction, masses in liver (mets, granuloma) and bone disease Gamma glutamyltransferase (GGTP) Specific to liver Increased in alcohol use, bile duct obstruction, masses in liver

66 AST and ALT Aspartate aminotransferase (AST)
Found in mitochondria and in cytosol Increased in many liver disease muscle injury (MI, rhabdomyolysis) Alanine aminotransferase (ALT) Found in cytosol “specific” to liver Elevated in many liver disease with inflammation and liver cell death

67 Diagnostic Tests for Hepatocellular
AST to ALT ratio AST> ALT usually alcohol use ALT>AST all other causes (viral hepatitis) HBsAg, Hep C antibody, HCV-PCR, IgM Hepatitis A Antinuclear antibody (ANA), smooth muscle antibody (SMA) Iron, TIBC, ferritin, HFE gene (hemochromatosis) Ceruloplasmin Alpha-1 antitrypsin level and phenotype

68 Case 2 Asian Family history of liver disease ?? Firm liver
Elevated ALT>AST DDx Chronic viral hepatitis (B or C) Hemochromatosis Wilson, Alpha-1 antitrypsin,

69 (Liver Biopsy, Masson Trichrome Stain
Cirrhosis (Liver Biopsy, Masson Trichrome Stain

70 Normal Values AST 10 – 32 U/L ALT 3 – 30 U/L
Bilirubin T/D <1.3 / <0.3 Alk Phosphatase 35 – 105 U/L GGT – 65 U/L Albumin Ceruloplasmin 40 – 80 Alpha-1 AT – 199

71 ERCP Double-Duct Sign

72 How Bad is the Liver Disease?
Laboratory tests Usually normal until patient develops cirrhosis Platelet count Bilirubin (especially direct) Albumin INR

73 How Bad is the Liver Disease?
Ultrasound and CT usually not helpful Liver spleen scan Redistribution to the bone marrow (more important than spleen) Liver biopsy Fibrosis Inflammation Etiology

74 Autoimmune Hepatitis Mieli-Vergani, G. & Vergani, D. (2011) Autoimmune hepatitis Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

75 What is the cause of liver injury?
History, PE Routine Lab tests Hepatocellular vs. obstructive “Special” lab tests

76 How Bad is the Liver Disease?
History Ascites, variceal bleeding, encephalopathy, Physical Examination Firm liver, splenomegaly Spider angiomas, palmar erythema Ascites, hepatic encephalopathy Laboratory tests Albumin, bilirubin (direct), INR Platelet, WBC Liver Biopsy

77

78 Stages of Fibrosis In Chronic Hepatitis
HCV - Natural History Stages of Fibrosis In Chronic Hepatitis Portal Periportal Septal Cirrhosis 1 2 3 4 Slide 202 Stages of Fibrosis In Chronic Hepatitis Most pathologist use a four-point system for staging fibrosis in chronic hepatitis, based on the amount of fibrosis seen in relation to the portal tract [Desmet VJ et al., Hepatology 1994;19:1513]. In stage 1, an increased amount of collagen expands the portal area. In stage 2, strands of fibrosis extend out from portal areas but do not interconnect. In stage 3, strands of fibrosis begin to connect from one portal tract to another, forming septa. In stage 4, or cirrhosis, the septa have formed a network of interconnecting bands surrounding nodules of liver cells. At this point, the original architecture of the liver has been completely transformed. (The Metavir Scoring System is described in more detail in slide 364.) Photo courtesy of Tom Smyrk, MD, Mayo Medical Center, Rochester, MN

79 What are we going to do about the liver disease?
Depends on cause of liver disease, severity of liver disease and patient’s wishes


Download ppt "Evaluation of Abnormal Liver Tests"

Similar presentations


Ads by Google